TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
about
Signaling mechanisms implicated in cranial sutures pathophysiology: CraniosynostosisUnravelling the molecular control of calvarial suture fusion in children with craniosynostosis.Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion.Comparison of craniofacial phenotype in craniosynostotic rabbits treated with anti-Tgf-beta2 at suturectomy site.The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosisThe BMP antagonist noggin regulates cranial suture fusion.Assessing age-related ossification of the petro-occipital fissure: laying the foundation for understanding the clinicopathologies of the cranial base.Molecular basis of cranial suture biology and disease: Osteoblastic and osteoclastic perspectivesDura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defectsAttenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.Cytokine therapy for craniosynostosis.Effects of Citalopram on Sutural and Calvarial Cell Processes.Application of Laser Capture Microdissection to Craniofacial Biology: Characterization of Anatomically Relevant Gene Expression in Normal and Craniosynostotic Rabbit Sutures.Force-induced craniosynostosis in the murine sagittal sutureCellular response to force application at craniofacial sutures.Remodeling the dentofacial skeleton: the biological basis of orthodontics and dentofacial orthopedics.A review of hedgehog signaling in cranial bone developmentDifferential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro.Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments.The role of vertebrate models in understanding craniosynostosis.Craniofacial surgery, from past pioneers to future promise.Models of cranial suture biology.Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development.Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cellsInhibition of osteogenic differentiation of human mesenchymal stem cellsTissue interactions between craniosynostotic dura mater and bone.Cloning of TgfβR1 and TgfβR2 and Likely Exclusion as Loci of Origin in a Rabbit Craniosynostotic Model.Delivery of Transforming Growth Factor-β3 Plasmid in a Collagen Gel Inhibits Cranial Suture Fusion in Rats.BMP9 induces osteogenesis and adipogenesis in the immortalized human cranial suture progenitors from the patent sutures of craniosynostosis patients.Timing of Egf treatment differentially affects Tgf-beta2 induced cranial suture closure.Smad7 modulates TGFβ signaling during cranial suture development to maintain suture patency.Mechanism of skull suture maintenance and interdigitation.Excessive retinoic acid inhibit mouse embryonic palate mesenchymal cell growth through involvement of Smad signaling
P2860
Q28073737-B3E44A5A-7A3D-4B36-AA9C-F96D1EA4F056Q33310098-20C5F3E5-E430-4A19-948D-47EA7276253DQ33505673-FB1B509B-4041-489C-B970-8E6F3DD9DDE5Q33720058-5C9F387B-CDC5-4382-A43C-79292DFEBBC3Q33987011-C1963CA0-922F-4875-8CBB-66DFDD49836EQ34018035-844E812B-D384-4AD6-A7D2-A8D66E2791FBQ34189687-8C80E9E4-942E-4126-A9CF-3E78664764C4Q34248955-BF48FD4A-29C1-48F6-925F-564AA782F31AQ34560898-C464DD67-3A69-4A20-B23D-C3CA8E42E5DBQ35159500-B25C70B0-C71C-44BF-B91E-0C4FC1161D39Q35214686-C1F63851-910F-4776-9EF5-634F05EE8310Q35684846-EDAD28DA-C348-4783-BD67-E2E237BBDA89Q35796871-6190FCE6-4C00-4406-99BC-EB11D5069273Q35949127-C453AB8C-325F-4296-8EB0-08C6AA462BB3Q36054809-BC7DD8D1-790D-4471-8D51-DADD9F308A68Q36570636-218EBC09-0D15-461B-A528-97DD93330077Q36692622-AF742C49-6B79-4171-B642-A42316D8DE27Q36732493-5FB62CB6-35BA-40B7-BCEB-A76BC17D7B2EQ37357714-DB814C03-9106-480A-98E3-7EE27BA295A3Q37719717-77473285-1886-4FCD-BCCE-75E47E9ECD64Q38032780-F7D58ACE-B126-4B53-AE36-B421DA0D4BB9Q38058778-C5765EF4-B868-44BC-8DBB-4496D5AB3933Q38060056-5B2789D1-5D66-4D54-8AA3-4C8C351101B7Q38308866-CEF43C22-4D3B-4361-A7BF-5981C720E969Q39155183-31121EB9-44A6-4F51-9BE4-6101C7B9B425Q39946596-67132E16-D7D4-4743-BF77-158B6DBBDFA5Q39971441-3381AFF0-E09B-4EDB-865F-686155372FC8Q39971776-ED8CC520-FE51-48D5-909C-E5D4E33E5429Q41905018-A853370B-0E88-48F7-92B5-83F51AAF52C3Q44850022-1449E552-B5B9-4742-A575-F1FFA7B394EFQ45089272-3DC0E126-E8D6-4EFD-B7A3-25FF4FFEF2C8Q47103852-458D4651-0EBB-4239-A323-3128FD41C672Q47301589-D792B765-BC4F-48D3-94C1-ADCA5DCEAB79Q47743466-59383FF8-D66E-4847-A316-4641E1F0C91FQ48439703-183B4B16-3E36-4BCB-9C2D-44B15219544CQ58165833-428144FA-3C29-473B-B821-81FA2C852AD8
P2860
TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@ast
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@en
type
label
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@ast
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@en
prefLabel
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@ast
TGF-beta 1, TGF-beta 2, and TG ...... teration in vivo and in vitro.
@en
P1476
TGF-beta 1, TGF-beta 2, and TG ...... iteration in vivo and in vitro
@en
P2093
P304
P356
10.1359/JBMR.1997.12.3.301
P577
1997-03-01T00:00:00Z